The FDA has removed the REMS program requirements for embryofetal toxicity risk from all endothelin receptor antagonist medications.

The FDA published over 200 response letters sent as replies to drug and biological product applications in order to increase transparency.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Hospital staffing shortages are expected as applicants from foreign countries are unable to get visas under the Trump administration.

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

Individuals with vs without knee, hip, or hand OA were associated with a significantly increased risk for sleep apnea.

The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.

Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

HealthDay News — The Trump administration may cut off federal funding to hospitals that provide gender-related treatments to children and teens.

Individuals with cystic fibrosis or CFTR gene variants have a 3-fold higher risk of developing pancreatic cancer after 50 years of age.

RFK Jr praised a meal service “without additives" for people on Medicaid and Medicare, but experts say that the meals are highly processed.

The likelihood of antiviral prescribing and dispensing among patients with influenza varied by care setting, patient age, and underlying medical conditions.